Vesalic

Vesalic develops therapeutic and diagnostic approaches for amyotrophic lateral sclerosis (ALS), focusing on the potential role of metabolic dysfunction outside the nervous system.

Its preclinical programmes include a treatment candidate designed to address toxic cargo carried by exosomes to motor neurons, alongside a blood test examining lipid signatures in extracellular vesicles.

The company is investigating whether these mechanisms could support earlier diagnosis and new treatment strategies.